Associate Director, Clinical Supply Chain (Biologics) at Abata Therapeutics

Waltham, Massachusetts, United States

Abata Therapeutics Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Bachelor’s or Master’s in a scientific discipline with 8+ years of relevant experience in clinical supply chain and logistics
  • Must have hands-on experience managing supply chain activities including but not limited to label

Responsibilities

  • Execute clinical supply chain activities including but not limited to labeling, packaging, distribution, inventory management, forecasting, IRT initiation, maintenance and expiry of clinical supplies
  • Author, review and/or approve clinical labels, packaging batch records, shipping documents, stability, clinical study, and pharmacy protocols
  • Serve as subject matter expert to generate label texts, distribution lanes, randomization codes, packaging specifications, and designs in compliance with regulations and GMPs
  • Support site initiation visits (SIV), trials and OLEs by providing timely delivery of supplies, CoAs, stability, expiration, handling and destruction information
  • Plan and adapt to changes against clinical demands, trial and protocol changes, expiration, and inventory management
  • Support clinical supply and logistics planning in support of global regulatory filings
  • Liaise with stakeholders to support timely approval and execution of SOPs, batch records, lot releases, change controls, deviations, and CAPAs
  • Support clinical distribution across US, Canada and EU through both IRT and manual driven site shipments and depot transfers
  • Verify with Quality the accuracy within blinded studies’ drug release, shipments & IRT setup
  • Identify and execute process improvements through report development and SOPs
  • Build strong relationships and partners with other leaders across CMC, quality, clinical operations, regulatory, and external CDMO/CPOs
  • Serve as person-in-plant (PIP) during label and packaging campaigns
  • 20-25% travel in support of diligence and campaign execution at the CPOs

Skills

Key technologies and capabilities for this role

Clinical Supply ChainBiologicsLabelingPackagingDistributionInventory ManagementForecastingIRTCMCClinical TrialsRegulatoryQuality

Questions & Answers

Common questions about this position

What is the work arrangement or location for this role?

The position is hybrid and based in Waltham, MA.

What is the salary for this position?

This information is not specified in the job description.

What key responsibilities or skills are required for this role?

The role requires executing clinical supply chain activities like labeling, packaging, distribution, inventory management, forecasting, and IRT management, plus authoring documents and serving as a subject matter expert on label texts, distribution, and packaging in compliance with regulations and GMPs.

What is the company culture like?

The company seeks top talent passionate about making a difference and eager to contribute to an engaged, inclusive, and positive company culture, while working in a fast-paced, high-touch environment.

What makes a strong candidate for this position?

Ideal candidates are experienced, motivated, highly communicative, enjoy fast-paced environments, establish strong cross-functional relationships, and can produce results effectively to support global clinical supply chain for biologics.

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI